Tag Archives: Breast
There is absolutely no way that any man can understand how women feel when they find a lump. Women are told and taught to check their breasts on a regular basis, to be constantly aware that early location will lessen risks in the worst case scenario. But how on earth does a woman feel if and when the nightmare is confirmed? A lump is found. First thought – What is it it? Was it there yesterday? Does it hurt? Please don’t let it be that ….. Then it is essential, completely and utterly and totally imperative that a medical opinion is sought. Some women are martyrs, and will probably wait, maybe hoping that the lump will disappear, and that nothing is really wrong. Some simply don’t want to be seen to be wasting the doctor’s time.
It is never a waste of time to have a lump checked. While most women are more prone to fluid retention than men, and more rapid changes in body composition, a lump is still a lump. Doctors, surgeons, and experts tend to base their collective diagnoses on several criteria. Like the age of the patient, her lifestyle, her current state of health, and whether her family has a history of breast cancer. Between 5 and 10 per cent of breast cancers are genetic, but if the family carries one of the genes there is an 85 per cent risk of cancer development. Obviously, once a medical consultation has taken place, there will be tests. Lots of tests. Genetic tests, which can now detect the breast and ovarian cancer gene BRCA1, mammagrams, or ultrasound tests. A woman needs a immense support at this time.
The waiting time varies, and the counselling sometimes might not be adequate. It probably helps, but what can possibly prepare any woman for the news that cancer is present, and a mastectomy is necessary? One, maybe both breasts will be lost. Not a finger. Not an ear. A breast. Something that men see. Something that men like. Something that a woman might use to snag a man. Something that makes her feel like a woman, sexy, attractive, vivacious. Something she needs in motherhood. Gone forever. So now it’s the 21st century, and surgical technology means that after months of chemotherapy, then a mastectomy, then radiotherapy and reconstructive surgery, a woman can look whole, even if she doesn’t quite feel it. But there’s the hair loss, the weight gain, the possibility of infertility, the constant testing on the lymph system, the weight gain, and the feeling of lost femininity.
Men have to help their partners out. Some women may have surgery to increase the size of the lost breasts, and may be more than happy with a new look. Men have to remember that a mastectomy leaves women with little or no feeling. Temporary saline implants are the norm, but increasingly are being replaced with tissue implants, using skin, fat, arteries and veins from another part of the body, usually the buttocks. These microsurgery techniques are carried out over a lengthy period of time, as a permanent breast is built, followed by nipple grafts. Breast cancer takes its toll on both women and men, but to have part of the anatomy removed must be truly crushing.
Although one must assume that women who have been diagnosed with cancer are happy to remain alive and well, the physical and emotional cost is high. With constant aftercare goes constant re-assurance. Fear that the cancer might re-appear. That it might have spread. Women just seem to cope so well. Guys, we need to help our women locate lumps, and in cancer cases, through the painful years afterwards. There is no comparison that a man can make. Maybe having his penis removed, and replaced with a non working piece of flesh, grafted from the buttocks. And how would we cope with that?
Sandy Francis is a recently retired sportsman, who now dedicates his time to his original vocation of writing. His latest website at http://www.dubbletake.110mb.com features articles and solutions on health, fitness, diet, and wellbeing.
Alternative remedies are more well-liked than ever, and women are now searching for “natural” solutions for the unpleasant symptoms of menopause. But natural doesn’t always mean safe. Actually, researchers have discovered that particular herbs possibly will raise a woman’s risk of breast cancer.
Even though there’s no direct data that the usage of herbs could increase or decrease the risk of breast cancer, in theory, a number of herbs have estrogen-like actions thus they shouldn’t be employed long-term or by women with a history of breast cancer or those at high risk. A number of these herbs include: black cohosh, blue cohosh, chasteberry, dang gui, dong quai and ginseng.
What about with traditional Chinese Medicine (TCM) connected with Chinese drugs?
Although there is no word for cancer in the annals of Traditional Chinese Medicine, there are many conditions with traditional names that would be diagnosed as cancer by physicians nowadays.
Ironically, modern physicians are commencement to know that cancer is not a solitary disease, but a lot of different ones. This lately adopted viewpoint is considering the view of Traditional Chinese Medicine.
The traditional Chinese treatment of cancer is rooted in the principle of Fu Zheng Gu Ben. “Fu Zheng” indicates strengthening what is correct. “Gu Ben” denotes regeneration and repair.
Treating cancer with Chinese herbs needs diagnosing the likely causes of the cancer, and then selecting the right course of treatment. Diagnosis is completed according to the four examinations. The goal of treatment is to harmonize the patient as well as it is to assault cancerous cells.
In recent years, the research on breast cancer has noted a steady decrease in newly diagnosed cases. Many people attribute this decrease to women accepting the fact that mammograms are a part of life. While mammograms play a significant part in early diagnosis and treatment, a reduction in new diagnosed cases is not linked to early detection. Breast cancer nutrition may be a primary reason for the significant reduction.
The Power of Fat and Breast Cancer Nutrition
Fat was once thought of as the worst ingredient in the diet. Many weight loss plans focused on reducing or eliminating fat from the diet. Thanks to studies on the healthy benefits of good fats, the Omega 3 rich fats have now been added back into the diet. Proper nutrition and Omega 3 rich oils can work together to empower the body to prevent cancer.
Not All Fats are the Same
Omega 3 rich oils need to be balanced with Omega 6 rich oils. Proper anticancer nutrition weighs heavily on this ratio, but unfortunately, many people consume much more Omega 6 than Omega 3. How is the balance maintained? Instead of consuming oils like corn oil, safflower oil and margarine, base your diet instead on olive oils and avocado oils. These oils are rich in Omega 3 fatty acids while the typical oils used for cooking are rich in Omega 6 fatty acids.
Omega 6 fatty acids are not bad for anticancer nutrition, but the huge difference between the amounts of Omega 6 rich oils and Omega 3 rich oils makes for reduced breast cancer fighting power.
How to Choose the Best Breast Cancer Nutrition Oils
When looking through the supermarket, it is important to add in unrefined oils in place of the refined oils.
Refined oils are used in fast food and restaurant setting as well as home cooking in many cases due to the reduced price of these oils. Paying a bit more at the supermarket for olive oil can work wonders for breast cancer prevention.
In addition to olive oil, sardines and walnuts are great sources of Omega 3 fatty acids. The focus may seem to be more on adding Omega 3 rich oils than Omega 6 rich oils. This is due to the overpowering amount of Omega 6 oils used in everyday life. The balance needs to be regained for breast cancer nutrition and the best way to regain that balance is to add more of the healthy oils that are lacking in the diet. In the case of breast cancer nutrition, that would be the Omega 3 fatty acids.
Receive a free consultation from a dietitian with the American Dietitians for Health.
HER2, belongs to the Epidermal Growth Factor receptor family, is one of The most vμlnerable oncogene in human tumor. HER2, a protein produced by a specific gene with cancer-causing potential. HER system including four epidermal growth factor receptor, Epidermal growth factor receptor is a kind of transmembrane glycoprotein with PTK activity, which have high expression in many epithelial tumour. Gefitinib (Iressa, ZD1839), a specific tyrosine kinase inhibitor that targets the epidermal growth factor receptor (EGFR), is a novel molecular-targeting antineoplastic agent. The new drug is targeted to treat breast cancers that carry a special genetic marker, known as HER2. HER2 play an important role in the growth and survival of cancer cells. her2 combination with Cancer cell, and then Formed enzyme. Enzymes will cause cancer cells continue to divide. breast cancer is a high incidence of tumors in women older than 40. Many women can reduce the incidence of breast cancer by the breast self-examination.
Breast self-examination does not diagnosed early breast cancer timely, The women is best to do breast examination regularly, breast X-ray mammography, ultrasound and MRI, CT scan, image positioning biopsy, nipple discharge examination can improve the early diagnosis of breast cancer. X-ray mammography can accurately diagnosed early breast cancer, X-ray mammography – accurate judgement of breast lesions benign and malignant degree. HER2-positive breast cancer patients have been diagnosed remain optimistic, Choose the best treatment options. To understand HER2 status is very important in breast cancer patients. Research shows that HER2-positivity affects approximately 20-30% of women with breast cancer. In breast cancer patient, her2 masculine breast cancer patient’s worsened speed often is higher than the negative patient. If determined that her2 is a masculine gender, should in view of her2 gene marching song proper bead Shan Kangba to the treatment, reduce the recrudescence risk promptly.
Breast cancer patients need to do HER2 testing, diagnosis of cancer was negative or positive. HER2-positive breast cancer survival time was 1 to 3 years, and HER2-negative patients survived at least 4 to 6 years. if check the status of HER2 in time and use the right treatment, Chances of survival of HER2-positive patients with breast cancer will be close to normal.
her2 Breast cancer self-examination does not diagnosed early breast cancer timely. http://www.cancer-c.com is a new star of Cancer Rehabilitation Website it will be to provide the latest information about Digital Mammography Traditional Chinese Medicine(TCM) Breast cancer treatment lung cancer mesothelioma Cancer Rehabilitation info
In the United States as a whole, breast cancer mortality rates have turned down to some extent in current years. That this is a recent trend is obvious from the fact that as long as the twenty years from 1970-1990, death rates demonstrated a small but considerable growth for white women of roughly 0.3 percent per year and a more considerable upsurge of 1.6 percent for black women.
In the United States, current view comes out to lend more weight to mammography screening and earlier diagnosis as the main cause for declining mortality rates, while in the UK and in Europe, where mortality rates have been declining more lately, the main present theories seem to good turn the wide usage of adjuvant tamoxifen as the cause. Because tamoxifen lowers mortality by nearly a third in long term studies of women with ER-positive breast cancers (approximately 75 percent of those diagnosed) this is surely a reasonable account.
Regular screening of women between the ages of 40 and 59 can considerably decrease breast cancer mortality in India, consistent with a study in the September 9 online issue of the Journal of the National Cancer Institute.
Breast cancer screening programs are habitually employed in developed countries where the occurrence of breast cancer is highest, and a wide health care system is prepared. The value and practicality of such screening programs in the developing world is less obvious. Even though the developing world has a lower breast cancer incidence rate, women be inclined to have more advanced disease at diagnosis and a greater risk of dying from their disease.
An important benefit of a screening program might be to recover the in general quality of care, as said by the editorialist, “but whether screening is the best method of reaching these significant purposes requires additional exploration.”
Early breast health education might be the important to lowering breast cancer mortality rates in Washington, D.C., which has the highest rates in the country, in accordance with research presented at the American Association for Cancer Research’s Seventh Annual International Conference on Frontiers in Cancer Prevention Research.
A new study proves that current declines in breast cancer mortality rates have been most considerable amongst women with estrogen receptor (ER)-positive tumors and women younger than 70.
A recent report indicates that removal of axillary lymph nodes may not improve breast cancer survival for some women. Data from this recently published study found that people with early-stage cancer that spreads to a nearby lymph node fared just as well after treatment without the removal of additional lymph nodes in the armpit area. This may be good news for patients.
Axillary Lymph Nodes & Breast Cancer Treatment
Breast cancer surgery often includes the removal of axillary lymph nodes (those in the armpit area) so doctors can check whether the cancer has spread. However, this procedure can cause swelling and stiffness in the arm, and in some extreme cases, lymphedema (fluid retention and tissue swelling due to a compromised lymphatic system).
It has long been the goal of breast surgeons to remove as few of these lymph nodes as clinically necessary. Lymph node status has been used to determine additional therapies for women diagnosed with cancer.
The study examined more than 800 patients with early-stage tumors. All the patients had only part of their breast removed (lumpectomy). Additionally, these patients had radiation therapy and some had chemotherapy.
In about half of the women, doctors also removed at least 10 axillary lymph nodes. Cancer was found in the axillary lymph nodes in 27% of the women in the study.
The study found, however, that the five-year survival rate was 91.8% in the women with axillary-node removal, compared with 92.5% who did not have those nodes removed.
The findings add to a collection of studies that have shown that less surgery combined with more radiation and chemotherapy may improve survival for women with cancer. This further demonstrates that the type of surgical intervention has little impact on overall outcomes.
If you have questions about any procedure your doctor is recommending, be an informed consumer of medicine and don’t hesitate to bring these issues up. The more comfortable you are with talking to your doctor about your health, the better.
What It Means
As is the case with most new studies, it is important to realize that the findings may have application in selected patients, and needs further validation before it becomes the standard. The data has reported only five year outcomes, which is a relative short time frame, but, a great start. Before becoming the standard of care, physicians involved in breast care will use this information to determine the best possible treatment plan for individual patients.
Breast cancer care is multidisciplinary, and collaboration of cancer specialists, including surgical, medical, and radiation oncologists, is paramount in determining the best treatment plans.
The author was named a top breast cancer surgeons in the Greater Detroit area. He is certified in ultrasound breast biopsies by the ASBS, is a member of The American Society of Breast Surgeons and The American Society of Breast Disease, and has served on the Membership Committee of the American Society of Breast Disease since 2007. Dr. Brown practices at Comprehensive Breast Care.